Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, PR China.
Biomaterials. 2010 Jun;31(18):4935-43. doi: 10.1016/j.biomaterials.2010.02.072. Epub 2010 Mar 25.
Several studies have validated successful mandibular reconstruction with prefabricated tissue-engineered bone flaps and recombinant human bone morphogenetic protein-2 (rhBMP-2) implanted in situ. Whether rhBMP-2 applied with the prefabrication technique enables faster ossification of mandibular defects than rhBMP-2 applied in situ is unknown. We aimed to compare mandibular reconstruction with prefabricated, vascularized tissue-engineered bone flaps with rhBMP-2 and rhBMP-2 applied in situ in primates (Rhesus monkey). We also compared the use of the carriers demineralized freeze-dried bone allograft (DFDBA) and coralline hydroxyapatite (CHA) for applying rhBMP-2. After computed tomography of the monkey head, custom meshes were made, loaded with rhBMP-2-incorporated DFDBA or CHA, and implanted in the latissimus dorsi muscle. Meanwhile, contralateral segmental mandibular defects were created, and custom meshes loaded with DFDBA, CHA, or rhBMP-2-incooperated DFDBA and CHA were implanted in situ. Thirteen weeks later, the bone flaps with rhBMP-2-incorporated DFDBA or CHA were transferred to repair segmental mandibular defects. The meshes loaded with DFDBA or CHA alone showed no bone regeneration 13 weeks after implantation in latissimus dorsi muscle. Radiography, angiography and histological analysis were used to evaluate the repair and vascularization of the implant. Segmental mandibular defects were successfully restored with prefabricated bone flaps and rhBMP-2-incorporated CHA in situ, but other segmental mandibular defects remained with rhBMP-2-incorporated DFDBA, DFDBA and CHA in situ. Moreover, mandibles reconstructed with rhBMP-2-incorporated CHA bone flaps revealed more regenerated and homogeneous bone formation than did other reconstructions. The study suggested that the prefabrication technique induced better mandibular reconstruction and bone regeneration in quantity and quality.
已有多项研究验证了预制组织工程骨瓣和局部植入重组人骨形态发生蛋白-2(rhBMP-2)在成功下颌骨重建中的作用。但尚不清楚预制技术联合 rhBMP-2 是否比单纯局部应用 rhBMP-2 能更快地促进下颌骨缺损的骨化。我们旨在比较预制血管化组织工程骨瓣联合 rhBMP-2 与 rhBMP-2 局部应用在灵长类动物(恒河猴)下颌骨重建中的效果。我们还比较了脱矿冻干骨(DFDBA)和珊瑚羟基磷灰石(CHA)两种载体在局部应用 rhBMP-2 中的效果。首先对头骨进行 CT 扫描,然后定制网片,将其装载入含有 rhBMP-2 的 DFDBA 或 CHA 后植入背阔肌。同时,在对侧下颌骨节段性缺损处,植入仅装载 DFDBA、CHA 或同时装载 DFDBA 和 CHA 的定制网片。13 周后,将装载 rhBMP-2 的 DFDBA 或 CHA 的骨瓣转移以修复下颌骨节段性缺损。13 周后,单独装载 DFDBA 或 CHA 的网片在背阔肌内均无骨再生。影像学、血管造影和组织学分析用于评估植入物的修复和血管化情况。预制骨瓣联合局部应用 rhBMP-2 和 CHA 成功修复了下颌骨节段性缺损,但其他节段性下颌骨缺损仍遗留有装载 rhBMP-2 的 DFDBA、DFDBA 和 CHA。此外,装载 rhBMP-2 的 CHA 骨瓣重建的下颌骨表现出更多的再生和更均匀的骨形成,优于其他重建。该研究表明,预制技术在数量和质量上均能更好地诱导下颌骨重建和骨再生。